INSTITUT CLAUDIUS REGAUD
🇫🇷France
A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation
Phase 2
Active, not recruiting
- Conditions
- NSCLC
- Interventions
- Combination Product: Radiotherapy + durvalumab
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 4
- Registration Number
- NCT03955198
- Locations
- 🇫🇷
Centre François Baclesse, Caen, France
🇫🇷Institut de Cancérologie de Bourgogne - Auxerre, Auxerre, France
🇫🇷Institut Sainte-Catherine, Avignon, France
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Other: Patients with a cancer for which a FDG-PET scanner must be performed
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 24
- Registration Number
- NCT03956459
- Locations
- 🇫🇷
Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
Platino-resistance in Ovarian Cancer
Not Applicable
Recruiting
- Conditions
- Epithelial Ovarian Cancer
- Interventions
- Other: Patients treated with platinum based-chemotherapy
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 600
- Registration Number
- NCT03954171
- Locations
- 🇫🇷
Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy
Not Applicable
Withdrawn
- Conditions
- Head and Neck Cancer
- Interventions
- Other: Helical intensity-modulated radiotherapy (IMRT)
- First Posted Date
- 2019-05-16
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- Institut Claudius Regaud
- Registration Number
- NCT03953352
- Locations
- 🇫🇷
Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O), Toulouse, France
Chronic Pain and Minor Breast Cancer Surgery
Completed
- Conditions
- Pain, PostoperativeSurgeryPain, ChronicBreast Cancer
- First Posted Date
- 2019-04-11
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 205
- Registration Number
- NCT03912948
- Locations
- 🇫🇷
Institut Claudius Regaud - IUCT-Oncopole, Toulouse, Occitanie, France
Evaluation of Pain and Postoperative Nausea Vomiting Incidence in Outpatient Surgery at IUCT-Oncopole Hospital
Completed
- Conditions
- CancerAnesthesiaSurgery
- Interventions
- Procedure: locoregional anesthesia
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 200
- Registration Number
- NCT03669328
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, Occitanie, France
FALCOn (Facteur AnthropoLogique Cancer Orl)
Completed
- Conditions
- Head and Neck CancerHead and Neck Carcinoma
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 206
- Registration Number
- NCT03663985
- Locations
- 🇫🇷
Institut Claudius Regaud, Toulouse, Occitanie, France
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
Phase 2
Active, not recruiting
- Conditions
- Breast Cancer Invasive
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 65
- Registration Number
- NCT03627988
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
🇫🇷Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse, France
Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients
Not Applicable
Completed
- Conditions
- Melanoma
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 78
- Registration Number
- NCT03627026
- Locations
- 🇫🇷
Chu Nantes, Nantes, France
🇫🇷Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse, France
Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.
Phase 2
Completed
- Conditions
- Oropharyngeal Squamous Cell Carcinoma
- Interventions
- Drug: Immunotherapy + Radiotherapy armDrug: Chemoradiotherapy arm
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Institut Claudius Regaud
- Target Recruit Count
- 11
- Registration Number
- NCT03623646
- Locations
- 🇫🇷
CHU Bordeaux, Bordeaux, France
🇫🇷Institut Universitaire du Cancer Toulouse (IUCT-O), Toulouse, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
© Copyright 2025. All Rights Reserved by MedPath